Acadia Pharmaceuticals Inc (ACAD)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
ACAD Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
ACAD Quarterly Deferred Revenue ($1.32M → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
ACAD deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,132,000 | |
| 2,644,000 | |
| 1,876,000 | |
| 513,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 15,000 | |
| 29,000 | |
| 42,000 | |
| 55,000 | |
| 80,000 | |
| 111,000 | |
| 140,000 | |
| 434,000 | |
| 266,000 | |
| 765,000 | |
| 683,000 | |
| 669,000 | |
| 708,000 | |
| 753,000 | |
| 462,000 | |
| 690,000 | |
| 6,680,000 | |
| 6,395,000 | |
| 6,089,000 | |
| 6,037,000 | |
| 5,904,000 | |
| 9,125,000 | |
| 92,000 | |
| 438,000 | |
| 170,000 | |
| 170,000 | |
| 170,000 | |
| 707,000 | |
| 1,664,000 | |
| 2,496,000 | |
| 3,125,000 | |
| 2,666,000 | |
| 2,791,000 | |
| 3,916,000 | |
| 4,041,000 | |
| 3,445,500 | |
| 4,167,900 | |
| 4,501,300 | |
| 5,834,600 | |
| 1,320,300 | |
| 1,653,600 | |
| 1,986,900 | |
| 2,320,300 | |
| 1,320,000 |